USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Artery Technology Company

USPTO PatentsView assignee record - 13 granted patents across 14 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H03K (Pulse Technique).

RSS updates for this company

The verdict

According to USPTO PatentsView, Artery ranks #20,767 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 14 technology areas.

#20,767
of 49,997 US assignees by volume
45th percentile
by Innovation Score (33.6/100)
13.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R20767 · Foreign Corporation #20,767 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,767/49,997
  • PHOTO-FINISH Armo Biosciences
  • CPC-FOCUS H03K · 14 areas
  • INNOV-THIN 33.6/100
  • CLAIMS-RICH 13.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Armo Biosciences, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Artery’s 33.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Artery

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Artery's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Artery?

Each dot is one of Artery’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Artery’s own 13.2 claims/patent is at or below the 13.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Artery vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 5101520 Granted patents (volume) Avg claims / patent Armo Biosciences, Inc. - 13, 18.92Armo BiosciencesArnold Umformtechnik GMBH & Co. KG - 13, 13.69Arnold Umformtech…Aroma System S.R.L. - 13, 8.92Aroma System S R LArrien Pharmaceuticals LLC - 13, 13.23Arrien Pharmaceut…Artskills, Inc. - 13, 11ArtskillsASM Assembly Systems Singapore PTE. Ltd. - 13, 17.46ASM Assembly Syst…Asset Guard Products Inc. - 13, 18.92Asset Guard Produ…Atec International Team Co., Ltd. - 13, 11.15Atec Internationa…Artery Technology Company - 13, 13.15Artery Technology
Artery vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Artery's grants concentrate

Artery Technology Company is a focused PatentsView assignee: 14 CPC subclasses with 61.5% of grants classified under H03K (Pulse Technique). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2021. By volume, Artery sits between Armo Biosciences, Inc. and Atec International Team Co., Ltd..

Artery's three-year grant acceleration

Artery Technology Company shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Artery's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Artery holds 13 patents at rank #20,726, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Artery

By rank, the assignees closest to #20,726 in granted patent volume.

Leaders in H03K (Pulse Technique)

Other assignees with the most granted patents in Artery's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Artery, neither rank-band nor same-CPC leaders (those blocks stay above). In H03K (Pulse Technique), Artery ranks #297 of 1,682 assignees by patent count in that subclass.

Artery's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20202021202220242025 1
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Artery Technology Company patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 7 53.8%
2021 1 7.7%
2022 3 23.1%
2024 1 7.7%
2025partial year 1 7.7%

Which technologies does Artery Technology Company patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Artery Technology Company's patent record in context - here's where to go next.

  • Artery Technology Company's lead technology class is H03K (Pulse Technique), 61.5% of its portfolio - see every assignee active in that class. Explore H03K
  • Ranked #20,767 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Artery Technology Company against Armo Biosciences, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.